GATA3 and breast carcinoma: This, together with our observations and those of Cimino-Mathews et al. [43] that breast cancer metastases generally maintain the expression of GATA3, leads us to suggest that current views of GATA3 as a putative tumor and/or metastasis suppressor in these tumors merit re-examination.